诙谐
发表于 2025-3-26 21:53:23
http://reply.papertrans.cn/19/1835/183425/183425_31.png
友好
发表于 2025-3-27 02:04:38
Australian experiences with hormonal contraception over two decadesries and from studies carried out at a time when preparations contained high doses of both estrogen and progestogen. The introduction of lower dosage and lower risk formulations underlines the need to identify and inform the woman at risk.
Generalize
发表于 2025-3-27 06:26:21
http://reply.papertrans.cn/19/1835/183425/183425_33.png
泛滥
发表于 2025-3-27 11:28:04
http://reply.papertrans.cn/19/1835/183425/183425_34.png
唤醒
发表于 2025-3-27 17:40:00
http://reply.papertrans.cn/19/1835/183425/183425_35.png
epicardium
发表于 2025-3-27 21:36:33
http://reply.papertrans.cn/19/1835/183425/183425_36.png
金哥占卜者
发表于 2025-3-27 23:46:57
http://reply.papertrans.cn/19/1835/183425/183425_37.png
Conspiracy
发表于 2025-3-28 05:10:14
http://reply.papertrans.cn/19/1835/183425/183425_38.png
良心
发表于 2025-3-28 07:40:32
http://reply.papertrans.cn/19/1835/183425/183425_39.png
chemical-peel
发表于 2025-3-28 11:47:55
Comparative investigation of oral contraceptives using randomized, prospective protocolsons have indeed reduced the incidence of some rare, but serious, side-effects of oral contraception.. Recently a new progestogen (desogestrel, ORG 2969) has also been introduced and claimed to have a more favorable impact on laboratory indices of cardiovascular risk.. The present study was undertake